Allen Bond

Global Pyrogen Testing Market: Trend Analysis and Forecast to 2022

Press Release   •   Feb 22, 2017 16:26 IST

Pyrogen increases body temperature after releasing or injecting into the human blood. Pyrogen comprises several groups of microbial and non-microbial substances that primarily cause fever. Pyrogens are lipopolysaccharide in nature, lipid part of pyrogen is pyrogenic whereas polysaccharide part increases the solubility. Symptoms of pyrogen include rise in body temperature, chills, body aches; rise in arterial blood pressure and cutaneous vasoconstriction are some of the reactions caused in the human body. Pharmaceutical companies use pyrogen testing to determine the presence of bacterial toxins in medical and veterinary products. The most powerful and most widely known pyrogens are the endotoxin and lipopolysaccharides, which are cell wall components of gram negative bacteria. In 2015, the size of global pyrogen testing market was valued over USD 550 million. The value of global pyrogen market is projected to grow with a CAGR between 11.5% – 12.0% over the forecast period of 2016-2022 and reach USD XXXX million by 2022.

Latest development in pharmaceutical research, increasing number of new drug launches and rapid growth in pharmaceutical and biotechnology industry are the major factors driving the growth of pyrogen testing market. Furthermore, augmented R&D investment in life science drug and increased government support in biotechnology and pharmaceutical industries likely to support the growth of pyrogen testing market. However, the increasing pressure to stop the usage of rabbits for pyrogen testing is likely to be the key restraining factor in the global pyrogen testing market. Stringent government regulation in the pharmaceutical industry are further restraining the market growth. Increasing marketing activities coupled with pharmaceutical outsourcing activities expected to bring more opportunities for major players in the market over the forecast period.

Segments Covered:

The report segments the pyrogen testing market by product type, by application, types of test and region. Market segmentation based on product includes Kits and Reagents Market, Services Market and Instruments Market. The application segment comprises pharmaceuticals and biological manufacturing, medical devices manufacturing and other applications. On the basis of types of tests market is segmented into vitro pyrogen test, LAL (Limulus amebocyte lysate) test and rabbit test.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, Latin America and Rest of the World. North America dominated the global pyrogen testing market and accounted market share of more than 38% in 2015. Presence of strong key players in the region, who responsible for big investment in R & D is expected to drive the dominance of North America over the forecast period. Furthermore, Asia pacific is anticipated to grow at a highest CAGR of 1x.x% over the forecast period owing to its growing population and increasing disposable income followed by Latin America. The emerging economies of Asia Pacific such as India, and China are the major contributors in growth of pyrogen testing market across the region. Moreover, low manufacturing cost of pharmaceutical products coupled with international medical facilities especially in India and China projected to drive market growth rapidly during the forecast period across the region.

Companies Profiled:

The companies covered in the report include

  • Associates of Cape Cod Inc
  • Charles River Laboratories International Inc
  • Lonza Group
  • Merck & Co Inc
  • Wako Chemicals USA Inc
  • Ellab A/S
  • Genscript
  • Hyglos Gmbh
  • Sigma-Aldrich Corporation
  • Thermo Fisher Scientific Inc

Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you’